Join the Leaders Advancing the Future of Molecular Glues
As molecular glue therapeutics move from promising discovery concepts to clinically validated modalities, the need to design, understand, and develop next-generation induced proximity medicines has never been greater. That's why the 5th Molecular Glue Drug Development Summit returns as the industry's premier meeting dedicated exclusively to advancing molecular glues from breakthrough discovery to clinical reality. Join 70+ leaders from pharma, biotech, academia, investment, and academia, including CXOs, VPs, Heads of Discovery, and academic pioneers, to explore:
- Glue discovery: rational discovery, screening, and profiling approaches to identify higher-quality candidates and expand target space
- Induced proximity biology: novel mechanisms beyond degradation, including stabilization, activation, inhibition, and rewiring
- AI-enabled design: platforms accelerating target identification, optimization, and mechanism prediction
- Translational science: biomarker strategies, preclinical models, and development frameworks that improve clinical success
2026 Event Highlights:
Accelerate Rational Molecular Glue Discovery
Learn how leading organisations are leveraging AI, machine learning, automation, advanced screening technologies, chemoproteomics, and computational modelling to make molecular glue discovery faster, more predictable, and increasingly rational.
Unlock New Biology Beyond Targeted Protein Degradation
Explore how molecular glues are being used to degrade, stabilize, activate, inhibit, and rewire protein function, opening new opportunities across oncology, neurodegeneration, immunology, inflammation, and rare disease.
Expand the E3 Ligase & Target Toolbox
Discover novel ligases, substrates, target classes, and discovery approaches that are broadening the universe of glueable proteins and unlocking previously undruggable biology.
Translate Discovery Into Clinical Success
Gain practical insights into mechanism validation, biomarkers, PK/PD strategy, patient selection, and clinical development considerations for molecular glue therapeutics.
Connect With the Leaders Driving the Field Forward
Network with senior scientists, drug developers, founders, investors, and executives during 7+ hours of dedicated networking.
Explore the 2026 Full Event Guide
- Get the complete agenda, speaker faculty, workshops, and networking opportunities in one place
- Explore the latest advances in molecular glue therapeutics, induced proximity biology, targeted protein degradation, and protein stabilization
- Discover how AI, computational modelling, automation, and structural biology are transforming rational glue discovery
- See which pharma, biotech, academic, and investment leaders are driving the next wave of proximity-based therapeutics
- Share with colleagues to evaluate scientific learnings, partnership opportunities, and commercial potential
2026 Attending Companies:
Explore the Agenda
Discover the latest advances in molecular glue therapeutics, induced proximity biology, AI-enabled drug discovery, targeted protein degradation, and translational development.
Partner With Us
Showcase your platform, technology, or services to the pharma, biotech, and academic leaders advancing next-generation molecular glue medicines.
Join Industry Leaders
Connect with the scientists, drug developers, investors, and decision-makers shaping the future of induced proximity therapeutics.